237 related articles for article (PubMed ID: 23639653)
1. Pyrazole derivatives as inhibitors of arachidonic acid-induced platelet aggregation.
Levent S; Çalışkan B; Çiftçi M; Özkan Y; Yenicesu I; Ünver H; Banoglu E
Eur J Med Chem; 2013 Jun; 64():42-53. PubMed ID: 23639653
[TBL] [Abstract][Full Text] [Related]
2. New 1H-pyrazole-4-carboxamides with antiplatelet activity.
Rehse K; Kotthaus J; Khadembashi L
Arch Pharm (Weinheim); 2009 Jan; 342(1):27-33. PubMed ID: 19051198
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anti-platelet activity of obovatol derivatives.
Kwak JH; Lee S; Park ES; In JK; Song J; Kim YJ; Choi NS; Lee H; Yun YP; Hong JT; Kwak YS; Min KH; Jung JK
Arch Pharm Res; 2011 Jul; 34(7):1107-12. PubMed ID: 21811917
[TBL] [Abstract][Full Text] [Related]
4. Dual anticoagulant/antiplatelet persulfated small molecules.
Correia-da-Silva M; Sousa E; Duarte B; Marques F; Cunha-Ribeiro LM; Pinto MM
Eur J Med Chem; 2011 Jun; 46(6):2347-58. PubMed ID: 21450376
[TBL] [Abstract][Full Text] [Related]
5. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
Brito FC; Kummerle AE; Lugnier C; Fraga CA; Barreiro EJ; Miranda AL
Eur J Pharmacol; 2010 Jul; 638(1-3):5-12. PubMed ID: 20412790
[TBL] [Abstract][Full Text] [Related]
6. 4-(1H-pyrazol-1-yl)-2-butylamine derivatives as inhibitors of blood platelet aggregation.
Ferroni R; Milani L; Simoni D; Orlandini P; Guarneri M; Franzé D; Bardi A
Farmaco; 1989 May; 44(5):495-502. PubMed ID: 2506876
[TBL] [Abstract][Full Text] [Related]
7. Amidinosemicarbazido derivatives of pyrazole: synthesis and inhibitory effect on blood coagulation and platelet aggregation.
Ferroni R; Milani L; Simoni D; Orlandini P; Poli T; Guarneri M; Taddeo U
Farmaco Sci; 1988 Nov; 43(11):891-9. PubMed ID: 3251783
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anti-platelet evaluation of 2-benzoylaminobenzoate analogs.
Hsieh PW; Chiang SZ; Wu CC; Lo YC; Shih YT; Wu YC
Bioorg Med Chem; 2008 May; 16(10):5803-14. PubMed ID: 18407506
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
[TBL] [Abstract][Full Text] [Related]
11. Solubilized phenyl-pyrazole ureas as potent, selective 5-HT(2A) inverse-agonists and their application as antiplatelet agents.
Dosa PI; Strah-Pleynet S; Jayakumar H; Casper M; Decaire M; Xiong Y; Lehmann J; Choi K; Elwell K; Wong A; Webb RR; Adams JW; Ramirez J; Richman JG; Thomsen W; Semple G; Teegarden BR
Bioorg Med Chem Lett; 2009 Sep; 19(18):5486-9. PubMed ID: 19665894
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity.
Wang WY; Hsieh PW; Wu YC; Wu CC
Biochem Pharmacol; 2007 Aug; 74(4):601-11. PubMed ID: 17601492
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet activity and structure-activity relationship study of Pyrazolopyridine Derivatives as potential series for treating thrombotic diseases.
Geraldo RB; Bello ML; Dias LR; Vera MA; Nagashima T; Abreu PA; Santos MB; Albuquerque MG; Cabral LM; Freitas AC; Kalil MV; Rodrigues CR; Castro HC
J Atheroscler Thromb; 2010 Jul; 17(7):730-9. PubMed ID: 20523012
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of baicalein derivatives as potential anti-aggregatory and anti-inflammatory agents.
Huang WH; Lee AR; Chien PY; Chou TC
J Pharm Pharmacol; 2005 Feb; 57(2):219-25. PubMed ID: 15720786
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of N6-alkyl(aryl)-2-alkyl(aryl)thioadenosines as antiplatelet agents.
Liu G; Xu J; Chen N; Zhang S; Ding Z; Du H
Eur J Med Chem; 2012 Jul; 53():114-23. PubMed ID: 22531380
[TBL] [Abstract][Full Text] [Related]
16. Rational Design and Synthesis of 1-(Arylideneamino)-4-aryl-1H-imidazole-2-amine Derivatives as Antiplatelet Agents.
Amidi S; Esfahanizadeh M; Tabib K; Soleimani Z; Kobarfard F
ChemMedChem; 2017 Jun; 12(12):962-971. PubMed ID: 28494138
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and inhibitory activities on platelet aggregation of some flavonoid analogues.
Göker H; Tunçbilek M; Leoncini G; Buzzi E; Mazzei M; Rolland Y; Ertan R
Arzneimittelforschung; 1995 Feb; 45(2):150-5. PubMed ID: 7710437
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of thioether derivatives of quinazoline-4-one-2-thione and evaluation of their antiplatelet aggregation activity.
Eskandariyan Z; Esfahani Zadeh M; Haj Mohammad Ebrahim Tehrani K; Mashayekhi V; Kobarfard F
Arch Pharm Res; 2014 Mar; 37(3):332-9. PubMed ID: 23856968
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel indole hydrazone derivatives and evaluation of their antiplatelet aggregation activity.
Mashayekhi V; Haj Mohammad Ebrahim Tehrani K; Amidi S; Kobarfard F
Chem Pharm Bull (Tokyo); 2013; 61(2):144-50. PubMed ID: 23154304
[TBL] [Abstract][Full Text] [Related]
20. N-substituted 4-carboxy-1-phenyl-1H-pyrazole-5-propanamides with antiinflammatory, analgesic, antipyretic and platelet antiaggregating activities.
Menozzi G; Mosti L; Schenone P; D'Amico M; Falzarano C; Rossi F
Farmaco; 1993 Apr; 48(4):539-49. PubMed ID: 8357469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
